William A. Haseltine | Academic Influence

William A. Haseltine's AcademicInfluence.com Rankings

William A. Haseltine

Biology

#2202

World Rank

#3525

Historical Rank

#993

USA Rank

Computational Biology

#39

World Rank

#39

Historical Rank

#15

USA Rank

Molecular Biology

#234

World Rank

#238

Historical Rank

#101

USA Rank

Biochemistry

#341

World Rank

#411

Historical Rank

#138

USA Rank

biology Degrees

William A. Haseltine

Philosophy

#2955

World Rank

#4893

Historical Rank

#989

USA Rank

Logic

#906

World Rank

#1475

Historical Rank

#312

USA Rank

philosophy Degrees

Download Badge

Biology
Philosophy

William A. Haseltine's Degrees

Doctorate Medicine Harvard University

Why Is William A. Haseltine Influential?

(Suggest an Edit or Addition)

According to Wikipedia, William A. Haseltine is an American scientist, businessman, author, and philanthropist. He is known for his groundbreaking work on HIV/AIDS and the human genome. Haseltine was a professor at Harvard Medical School, where he founded two research departments on cancer and HIV/AIDS. He is a founder of several biotechnology companies, including Cambridge Biosciences, The Virus Research Institute, ProScript, LeukoSite, Dendreon, Diversa, X-VAX, and Demetrix. He was a founder chairman and CEO of Human Genome Sciences, a company that pioneered the application of genomics to drug discovery.

(See a Problem?)

William A. Haseltine's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Complete nucleotide sequence of the AIDS virus, HTLV-III (1985) (2071)
Mutation of a mutL homolog in hereditary colon cancer. (1994) (1957)
Mutations of two P/WS homologues in hereditary nonpolyposis colon cancer (1994) (1620)
Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. (1987) (828)
Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. (1989) (797)
Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity (1986) (759)
Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells. (1984) (720)
Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. (1991) (698)
The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat (1985) (682)
A second post-transcriptional trans-activator gene required for HTLV-III replication (1986) (582)
The trans-activator gene of the human T cell lymphotropic virus type III is required for replication (1986) (573)
Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. (1985) (556)
Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes (1992) (484)
Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III. (1985) (477)
Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat. (1985) (443)
Structural and functional characterization of human immunodeficiency virus tat protein (1989) (438)
Synthesis of guanosine tetra- and pentaphosphate requires the presence of a codon-specific, uncharged transfer ribonucleic acid in the acceptor site of ribosomes. (1973) (435)
Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding (1990) (432)
Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions (1989) (377)
Human immunodeficiency virus vpr product is a virion-associated regulatory protein (1990) (372)
Transformation to continuous growth of primary human T lymphocytes by human T-cell leukemia virus type I X-region genes transduced by a Herpesvirus saimiri vector. (1989) (356)
UV-induced mutation hotspots occur at DNA damage hotspots (1982) (337)
Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus. (1988) (332)
Role of human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocytes in culture (1992) (318)
A transcriptional activator protein encoded by the x-lor region of the human T-cell leukemia virus. (1985) (318)
Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex (1991) (308)
Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein (1994) (307)
Identification of a protein encoded by the vpu gene of HIV-1 (1988) (305)
Cellular transcription factors and regulation of IL-2 receptor gene expression by HTLV-I tax gene product. (1988) (298)
Herpes simplex virus type-1 can reactivate transcription of latent human immunodeficiency virus (1987) (296)
gamma Ray induced deoxyribonucleic acid strand breaks. 3' Glycolate termini. (1983) (286)
Functional role of human immunodeficiency virus type 1 vpu. (1989) (282)
Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein (1993) (279)
Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoproteins. (1992) (279)
Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants (1990) (274)
MSI and MSII made on Ribosome in Idling Step of Protein Synthesis (1972) (271)
Inhibition of human immunodeficiency virus syncytium formation and virus replication by castanospermine. (1987) (271)
Identification of HIV-1 vpr product and function. (1990) (270)
Post-transcriptional regulation accounts for the trans-activation of the human T-lymphotropic virus type III (1986) (264)
Determination of the leukaemogenicity of a murine retrovirus by sequences within the long terminal repeat (1984) (262)
Reduction of adriamycin to a semiquinone-free radical by NADPH cytochrome P-450 reductase produces DNA cleavage in a reaction mediated by molecular oxygen. (1981) (257)
Integration of human immunodeficiency virus type 1 DNA in vitro. (1990) (255)
Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody. (1993) (255)
Cleavage of pyrimidine dimers in specific DNA sequences by a pyrimidine dimer DNA-glycosylase of M. luteus (1980) (240)
Sequence specific cleavage of DNA by the antitumor antibiotics neocarzinostatin and bleomycin. (1978) (230)
Distribution of UV light-induced damage in a defined sequence of human DNA: detection of alkaline-sensitive lesions at pyrimidine nucleoside-cytidine sequences. (1981) (220)
Range of radiochemical damage to DNA with decay of iodine-125. (1981) (220)
Effects of mutations within the 3' orf open reading frame region of human T-cell lymphotropic virus type III (HTLV-III/LAV) on replication and cytopathogenicity (1986) (220)
Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions. (1986) (219)
Activation of human immunodeficiency virus by herpesvirus infection: identification of a region within the long terminal repeat that responds to a trans-acting factor encoded by herpes simplex virus 1. (1987) (219)
Transepithelial transport of HIV-1 by intestinal M cells: a mechanism for transmission of AIDS. (1991) (217)
Sites and structure of gamma radiation-induced DNA strand breaks. (1982) (207)
Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses. (1993) (207)
Molecular biology of the human immunodeficiency virus type 1 (1991) (202)
Tissue-specific transcription preference as a determinant of cell tropism and leukaemogenic potential of murine retroviruses (1984) (173)
Antigens encoded by the 3'-terminal region of human T-cell leukemia virus: evidence for a functional gene. (1984) (172)
HIV/HTLV gene nomenclature (1988) (162)
Hepatitis B virus infection in cultured human lymphoblastoid cells. (1983) (161)
Enzyme action at 3' termini of ionizing radiation-induced DNA strand breaks. (1983) (160)
Rous sarcoma virus genome is terminally redundant: the 5' sequence. (1977) (160)
Mutational analysis of the 5′ non‐coding region of human immunodeficiency virus type 1: effects of secondary structure on translation. (1988) (158)
Gene transfer into human lymphocytes by a defective human immunodeficiency virus type 1 vector (1991) (153)
Structure of 3' terminal region of type II human T lymphotropic virus: evidence for new coding region. (1984) (149)
Comparison of the cleavage of pyrimidine dimers by the bacteriophage T4 and Micrococcus luteus UV-specific endonucleases. (1980) (149)
Subcellular localization of the human immunodeficiency virus trans-acting art gene product (1988) (147)
Alkylating agent resistance: in vitro studies with human cell lines. (1985) (147)
Circularization of human immunodeficiency virus type 1 DNA in vitro (1991) (147)
Replication of human immunodeficiency virus type 1 in primary dendritic cell cultures. (1991) (143)
Ordered transcription of RNA tumor virus genomes. (1976) (141)
Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors. (1995) (141)
Changes in the transmembrane region of the human immunodeficiency virus type 1 gp41 envelope glycoprotein affect membrane fusion (1990) (140)
Attenuation of human immunodeficiency virus type 1 cytopathic effect by a mutation affecting the transmembrane envelope glycoprotein (1991) (130)
Low-molecular-weight RNAs of Moloney murine leukemia virus: identification of the primer for RNA-directed DNA synthesis (1977) (129)
Nucleotide Sequence of the Akv env Gene (1982) (128)
Genetic analysis of the human immunodeficiency virus type 1 integrase protein (1994) (127)
Tissue selectivity of murine leukemia virus infection is determined by long terminal repeat sequences (1985) (127)
Requirement of the Pr55gag precursor for incorporation of the Vpr product into human immunodeficiency virus type 1 viral particles (1994) (127)
Alkaline lability of fluorescent photoproducts produced in ultraviolet light-irradiated DNA. (1982) (124)
Location of cis-acting regulatory sequences in the human T-cell leukemia virus type I long terminal repeat. (1985) (124)
Genomic changes associated with antigenic variation of visna virus durig persistent infection. (1980) (123)
Ultraviolet light repair and mutagenesis revisited (1983) (122)
Trans-activator gene of HTLV-II induces IL-2 receptor and IL-2 cellular gene expression. (1986) (120)
The molecular biology of the AIDS virus. (1988) (114)
Use of exonuclease III to determine the site of stable lesions in defined sequences of DNA: the cyclobutane pyrimidine dimer and cis and trans dichlorodiammine platinum II examples. (1981) (110)
Transcellular transactivation by the human immunodeficiency virus type 1 tat protein (1991) (108)
Inhibition of replication of HIV-1 by retroviral vectors expressing tat-antisense and anti-tat ribozyme RNA. (1992) (107)
Identification of cis-acting repressive sequences within the negative regulatory element of human immunodeficiency virus type 1 (1990) (104)
Specificity of deoxyribonucleic acid cleavage by bleomycin, phleomycin, and tallysomycin. (1982) (104)
Subcellular localization of the product of the long open reading frame of human T-cell leukemia virus type I. (1985) (104)
The art gene product of human immunodeficiency virus is required for replication (1988) (102)
Mechanism of action of a mammalian DNA repair endonuclease. (1986) (99)
Effects of long terminal repeat mutations on human immunodeficiency virus type 1 replication (1989) (96)
Specific binding of tryptophan transfer RNA to avian myeloblastosis virus RNA-dependent DNA polymerase (reverse transcriptase). (1975) (94)
Trans activation of the bovine leukemia virus long terminal repeat in BLV-infected cells. (1985) (93)
Novel leukaemogenic retroviruses isolated from cell line derived from spontaneous AKR tumour (1981) (89)
Construction of recombinant murine retroviruses that express the human T-cell leukemia virus type II and human T-cell lymphotropic virus type III trans activator genes (1986) (87)
Biochemical evidence that "new" influenza virus strains in nature may arise by recombination (reassortment). (1978) (87)
Envelope glycoprotein and CD4 independence of vpu-facilitated human immunodeficiency virus type 1 capsid export (1992) (84)
Evidence of extrachromosomal forms of hepatitis B viral DNA in a bone marrow culture obtained from a patient recently infected with hepatitis B virus. (1984) (84)
Cyclobutane pyrimidine dimers and (6-4) photoproducts block polymerization by DNA polymerase I. (1985) (82)
A tripartite HIV‐1 tat‐env‐rev fusion protein. (1990) (81)
Escherichia coli DNA photolyase reverses cyclobutane pyrimidine dimers but not pyrimidine-pyrimidone (6-4) photoproducts. (1985) (81)
T4 DNA polymerase (3'-5') exonuclease, an enzyme for the detection and quantitation of stable DNA lesions: the ultraviolet light example. (1985) (80)
Integrase mutants of human immunodeficiency virus type 1 with a specific defect in integration (1994) (78)
Silent HIV infections. (1989) (78)
Quantitation of cyclobutane pyrimidine dimer formation in double- and single-stranded DNA fragments of defined sequence. (1982) (76)
The C-C (6-4) UV photoproduct is mutagenic in Escherichia coli. (1986) (76)
Modification of DNA by aflatoxin B1 creates alkali-labile lesions in DNA at positions of guanine and adenine. (1978) (75)
Structural determination of the ultraviolet light-induced thymine-cytosine pyrimidine-pyrimidone (6-4) photoproduct. (1985) (75)
A micromethod for detailed characterization of high molecular weight RNA. (1980) (74)
Replication and pathogenesis of the AIDS virus. (1988) (74)
Cis-acting sequences responsive to the rev gene product of the human immunodeficiency virus. (1988) (73)
A new relaxed mutant of Escherichia coli with an altered 50S ribosomal subunit. (1974) (72)
In vitro Transcription of Escherichia coli Ribosomal RNA Genes (1972) (71)
Allelic variation in the effects of the nef gene on replication of human immunodeficiency virus type 1. (1991) (70)
Multiple sequence elements are required for regulation of human T-cell leukemia virus gene expression. (1987) (65)
Affordable Excellence: The Singapore Healthcare Story (2013) (65)
The role of the (6-4) photoproduct in ultraviolet light-induced transition mutations in E. coli. (1986) (65)
Functional analysis of the phosphorylation sites on the human immunodeficiency virus type 1 Vpu protein. (1995) (64)
Repetitive structure in the long-terminal-repeat element of a type II human T-cell leukemia virus. (1984) (64)
Constitutive expression of HIV-1 tat protein in human Jurkat T cells using a BK virus vector. (1990) (63)
Development of methotrexate resistance in a human squamous cell carcinoma of the head and neck in culture. (1984) (62)
Long terminal repeat structure of an American isolate of type I human T-cell leukemia virus. (1984) (62)
Influence of human T-cell leukemia virus type I tax and rex on interleukin-2 gene expression (1993) (62)
Identification of a region within the human immunodeficiency virus type 1 long terminal repeat that is essential for transactivation by the hepatitis B virus gene X (1989) (62)
Glycosylation and processing of the human immunodeficiency virus type 1 envelope protein. (1989) (61)
Response of the human T-cell leukemia virus type 1 long terminal repeat to cyclic AMP (1989) (60)
Postexposure chemoprophylaxis with ZDV or ZDV combined with interferon-alpha: failure after inoculating rhesus monkeys with a high dose of SIV. (1991) (59)
Substrate specificity of a mammalian DNA repair endonuclease that recognizes oxidative base damage (1986) (58)
Gerontological Society of America (2001) (57)
Mechanism of induction of RNA tumor viruses by halogenated pyrimidines. (1975) (57)
Structure of the genome of moloney murine leukemia virus: a terminally redundant sequence (1978) (56)
High ratio of alkali-sensitive lesions to total DNA modification induced by benzo(a)pyrene diol epoxide. (1984) (55)
Construction and use of a replication-competent human immunodeficiency virus (HIV-1) that expresses the chloramphenicol acetyltransferase enzyme. (1989) (55)
Terminal redundancy and the origin of replication of Rous sarcoma virus RNA. (1977) (54)
Antibodies to CD4 in individuals infected with human immunodeficiency virus type 1. (1989) (53)
The NF-kappa B p65 promoter. (1993) (53)
Expression of reverse transcriptase activity of human T-lymphotropic virus type III (HTLV-III/LAV) in Escherichia coli (1986) (52)
Isolation of UV-resistant revertants from a xeroderma pigmentosum complementation group A cell line (1984) (51)
Removal of UV light-induced pyrimidine-pyrimidone(6-4) products from Escherichia coli DNA requires the uvrA, uvrB, and urvC gene products. (1984) (51)
ULTRAVIOLET LIGHT IRRADIATION OF DEFINED‐SEQUENCE DNA UNDER CONDITIONS OF CHEMICAL PHOTOSENSITIZATION (1985) (51)
Sequence of the envelope glycoprotein gene of type II human T lymphotropic virus. (1984) (51)
Polymorphism of the 3' open reading frame of the virus associated with the acquired immune deficiency syndrome, human T-lymphotropic virus type III. (1985) (50)
Molecular cloning of a highly leukemogenic, ecotropic retrovirus from an AKR mouse (1982) (50)
Action spectrum for the formation of endonuclease-sensitive sites and (6-4) photoproducts induced in a DNA fragment by ultraviolet radiation. (1986) (49)
Analysis of the genome of an endogenous, ecotropic retrovirus of the AKR strain of mice: micromethod for detailed characterization of high-molecular-weight RNA (1980) (48)
Biological and biochemical characterization of an SV40-transformed xeroderma pigmentosum cell line. (1984) (47)
Characterization of the cDNA of a broadly reactive neutralizing human anti-gp120 monoclonal antibody. (1992) (46)
The effect of vpu on HIV-1-induced syncytia formation. (1993) (45)
Mutational analysis of the human immunodeficiency virus type 1 Eli Nef function. (1992) (44)
A major retroviral core protein related to EPA and TIMP (1985) (43)
Similarities among retrovirus proteins (1984) (43)
Localization of the leukemogenic determinants of SL3-3, an ecotropic, XC-positive murine leukemia virus of AKR mouse origin (1983) (43)
Structural basis for the deoxyribonucleic acid affinity of bleomycins. (1982) (42)
Interaction of tryptophan tRNA and avian myeloblastosis virus reverse transcriptase: further characterization of the binding reaction. (1977) (42)
HTLV-I p27rex regulates gag and env protein expression. (1989) (41)
Billion-dollar market blossoms as botanicals take root (1999) (41)
Effect of nef alleles on replication of human immunodeficiency virus type 1. (1993) (41)
Transforming potential of a human protooncogene (c-fps/fes) locus. (1984) (41)
Detection of hepatitis B virus X product using an open reading frame Escherichia coli expression vector. (1986) (40)
Thermolability of the stringent factor in rel mutants of Escherichia coli. (1973) (40)
Complex-type N-linked oligosaccharides of gp120 from human immunodeficiency virus type 1 contain sulfated N-acetylglucosamine (1993) (38)
Malondialdehyde precursors in gamma-irradiated DNA, deoxynucleotides and deoxynucleosides. (1985) (37)
Nucleotide excision repair of damaged DNA. (1979) (36)
Development of antiviral drugs for the treatment of AIDS: strategies and prospects. (1989) (36)
Activation of enhancer sequences in type II human T-cell leukemia virus and bovine leukemia virus long terminal repeats by virus-associated trans-acting regulatory factors (1986) (35)
Serological cross-reactivity between envelope gene products of type I and type II human T-cell leukemia virus. (1984) (34)
Early molecular replication of human immunodeficiency virus type 1 in cultured-blood-derived T helper dendritic cells. (1993) (34)
Identification of Membrane Anchorage Domains of the HIV‐1 gp160 Envelope Glycoprotein Precursor (1991) (34)
The Emergence of Regenerative Medicine: A New Field and a New Society (2001) (33)
The 3′ region of bovine leukemia virus genome encodes a trans‐activator protein. (1986) (33)
Genetic structure and regulation of HIV (1991) (33)
Identification of a protein encoded by the trans activator gene tatIII of human T-cell lymphotropic retrovirus type III (1986) (33)
Beyond chicken soup. (2001) (32)
Use of an indicator sequence of human DNA to study DNA damage by methylbis(2-chloroethyl)amine. (1980) (32)
Regulatory elements within the murine leukemia virus enhancer regions mediate glucocorticoid responsiveness (1988) (32)
Glucocorticoid regulation of murine leukemia virus transcription elements is specified by determinants within the viral enhancer region (1987) (32)
Gibbon ape leukemia virus-Hall's Island: new strain of gibbon ape leukemia virus (1979) (31)
Not quite pharmacogenomics (1998) (31)
Preferred sites of strand scission in DNA modified by andi-diol epoxide of benzo[a]pyrene. (1980) (31)
Sequence similarity among retroviruses—erratum* (1984) (31)
Suppression of retroviral propagation and disease by suramin in murine systems. (1985) (31)
Most sequence differences between the genomes of the Akv virus and a leukemogenic Gross A virus passaged in vitro are located near the 3' terminus. (1980) (30)
A rapid method for quantitating the frequency of peripheral blood cells containing HIV-1 DNA. (1991) (29)
5′-Terminus of Moloney Murine Leukemia Virus 35S RNA Is m7G5′ ppp5′ GmpCp (1976) (29)
In Vitro Synthesis of ppGpp and pppGpp (1974) (27)
Ganglioside-induced CD4 endocytosis occurs independent of serine phosphorylation and is accompanied by dissociation of P56lck. (1992) (27)
Protein kinase A-dependent binding of a nuclear factor to the 21-base-pair repeat of the human T-cell leukemia virus type I long terminal repeat (1990) (26)
A method for classification of 5′ termini of retroviruses (1978) (26)
gp160 of HIV-I synthesized by persistently infected Molt-3 cells is terminally glycosylated: evidence that cleavage of gp160 occurs subsequent to oligosaccharide processing. (1991) (25)
Structure of retroviral RNAs produced by cell lines derived from spontaneous lymphomas of AKR mice (1982) (25)
The use of DNA fragments of defined sequence for the study of DNA damage and repair. (1980) (25)
INFECTION OF BONE MARROW CELLS BY HEPATITIS B VIRUS (1983) (24)
Disulfide bond formation in the human immunodeficiency virus type 1 Nef protein (1993) (24)
Risks of handling HIV (1991) (24)
Size of murine RNA tumor virus-specific nuclear RNA molecules (1976) (23)
Infection of accessory dendritic cells by human immunodeficiency virus type 1. (1992) (23)
Genetics Policy Institute (2006) (23)
Characterization of virus produced by a lymphoma induced by inoculation of AKR MCF-247 virus (1980) (22)
Discovering genes for new medicines. (1997) (22)
Rex-dependent nucleolar accumulation of HTLV-I mRNAs. (1991) (22)
Effects on CD4 binding of anti-peptide sera to the fourth and fifth conserved domains of HIV-1 gp120. (1990) (21)
The role of the tnv protein and tnv RNA splicing signals in replication of HIV-1 IIIB isolates. (1992) (21)
HIV ENVELOPE-CD4 INTERACTION NOT INHIBITED BY SYNTHETIC OCTAPEPTIDES (1987) (20)
Expression of the art gene protein of human T-lymphotropic virus type III (HTLV-III/LAV) in bacteria (1987) (20)
Photoreactivation of Escherichia coli reverses umuC induction by UV light (1985) (20)
Early steps of excision repair of cyclobutane pyrimidine dimers by the Micrococcus luteus endonuclease. A three-step incision model. (1981) (20)
New methods for detection of low levels of DNA damage in human populations. (1983) (20)
AIDS virus and scrapie agent share protein (1986) (19)
Structure of products of the Moloney murine leukemia virus endogenous DNA polymerase reaction (1979) (18)
Interview with David A. Sinclair, Ph.D. (2008) (17)
Infection of human natural killer (NK) cells with replication-defective human T cell leukemia virus type I provirus. Increased proliferative capacity and prolonged survival of functionally competent NK cells. (1992) (17)
FINDING THE NEEDLE IN THE HAYSTACK (1999) (17)
Interview with John Vincent, Ph.D. (2009) (16)
Structure and function of the genome of HTLV. (1985) (16)
The NF kappa B independent cis-acting sequences in HIV-1 LTR responsive to T-cell activation. (1991) (16)
Isolation and characterization of a human locus homologous to the transforming gene (v-fes) of feline sarcoma virus. (1982) (16)
Regenerative Medicine 2003: An Overview (2003) (16)
The power of genomics to transform the biotechnology industry (1998) (16)
American Federation for Aging Research (1999) (15)
The T open reading frame of human immunodeficiency virus type 1. (1990) (15)
Cell lines that express stably env gene products from three strains of HIV-1. (1988) (15)
ATMOSPHERIC ABSORPTION OF CO2 LASER RADIATION (1967) (14)
Nucleotide sequence of Rous sarcoma virus RNA at the initiation site of DNA synthesis: The 102nd nucleotide is U. (1977) (14)
American Federation for Aging Research: Interview with Stephanie Lederman (2009) (14)
IN VITRO REPLICATION OF RNA TUMOR VIRUSES (1976) (14)
5'-terminal nucleotide sequences of mammalian type C helper viruses are conserved in the genomes of replication-defective mammalian transforming viruses (1978) (13)
An Amino‐Terminal Amino Acid Affects the Electrophoretic Mobility of the HIV‐1 Nef Protein (1992) (13)
A nuclear factor is required for transactivation of HTLV-I gene expression. (1988) (12)
Substrate range of the 40,000-dalton DNA-photoreactivating enzyme from Escherichia coli. (1986) (12)
Interview: commercial translation of cell-based therapies and regenerative medicine: learning by experience. Interview by Emily Culme-Seymour. (2011) (12)
Regulatory genes of human immunodeficiency viruses. (1992) (12)
Reexamination of the coding potential of the HTLV-1 pX region. (1992) (12)
Transcription directed by the HIV long terminal repeat in vitro. (1987) (12)
Gail Thomson, M.D. Health Protection Agency (HPA), Porton, United Kingdom. (2012) (11)
Comparative analysis of the genomes of feline leukemia viruses (1980) (11)
Sequence similarity among retroviruses (1984) (11)
Sinton Bands: Evidence for Deuterated Water on Mars (1965) (10)
Mechanisms of infectivity and replication of HIV-1 and implications for therapy. (1990) (10)
The potential for homeostatic regulation of the X region proteins of the human T cell leukemia virus type I. (1989) (10)
A transfection assay for transformation by feline sarcoma virus proviral DNA. (1980) (9)
Encephalization in Proconsul africanus (1984) (9)
Relationship of retroviruses isolated from human leukemia tissues to the woolly monkey-gibbon ape leukemia viruses (1980) (8)
Antibodies to CD 4 in individuals infected with human immunodeficiency virus type 1 (8)
Cell membrane fusion mediated by the envelope glycoproteins as the primary effector of aids virus cytopathicity (1987) (8)
4 – Human Immunodeficiency Virus (HIV) Gene Expression and Function (1991) (7)
U.S. skin-replacement market could heat up (1995) (7)
Role of the human immunodeficiency virus type I envelope glycoprotein in cytopathic effect. (1991) (6)
Expression of enzymatically active reverse transcriptase of simian immunodeficiency virus in bacteria: sensitivity to nucleotide analogue inhibitors. (1990) (6)
The role of vif in replication of Hiv - 1 in Cd4+ T lymphocytes (1993) (6)
p21rex protein of HTLV-1. (1990) (6)
Regenerative Medicine: A Future Healing Art (2003) (6)
Variation among the human T-cell lymphotropic virus type III (HTLV-III/LAV) strains. (1987) (6)
Structural analysis of the genomes of gibbon ape and woolly monkey leukosis viruses (1979) (5)
Genomics and drug discovery. (2001) (5)
Location ofcis-acting regulatory sequences inthehumanT-cell leukemia virus typeIlongterminal repeat (1985) (5)
Conflicts brewing as phage display gets complex (1997) (5)
Erratum: Atmospheric Absorption of CO2 Laser Radiation (1967) (5)
Gerontology Research Group. (2003) (5)
Apart from that… (1991) (5)
Isolation via transfection of feline leukemia viruses from DNA of naturally occurring feline lymphomas. (1981) (4)
Can ReoPro repolish tarnished monoclonal therapeutics? (1996) (4)
Reducing the Cost of Peptide Synthesis (2013) (4)
Telehealth for managing COPD. (2009) (4)
Comparative analysis of RNA tumor virus genomes. (1979) (4)
Universal Disease Screening and Treatment - The Egyptian Example. (2020) (4)
Trans-activator gene of HTLV-II: interpretation. (1987) (4)
Replication and pathogenesis of the human T-cell leukemia/lymphotropic retroviruses. (1987) (4)
Interview with Willy Burgdorfer, Ph.D. (2006) (3)
Examination of HTLV-III. (1987) (3)
Fake blood market gets hemoglobin transfusion from reticulocytes (1998) (3)
In vitro studies of the replication of Moloney murine leukemia virus. (1979) (3)
Liposomal antifungals battle for market share (1995) (3)
The lor gene and pathogenesis of HTLV-I, -II, and -III. (1985) (3)
An Interview with Doriano Fabbro, Ph.D., Novartis Biomedical Research Institute (2004) (3)
An Interview with Keith Cheng, M.D., Ph.D. (2006) (3)
Of how great significance? (1987) (3)
UCSF targets cancer IND (1998) (3)
Lilly and Millenium cut the genome cake a new way (1995) (3)
Similarities among the pre-S regions of hepatitis B viruses: analogy with retroviral transmembrane proteins. (1986) (3)
An Interview with Stephen Michnick, Ph.D., Associate Professor, Department of Biochemistry, University of Montreal (2004) (3)
Chromatography: Primer and Current Practice (1986) (3)
EC and US agencies fund large-scale Arabidopsis sequencing (1996) (3)
Expression of the x-lor gene of human T-cell leukemia virus I in Escherichia coli (1985) (3)
Long-Term Care Financing (2019) (2)
Status of Cell and Gene Therapy Keeps Vacillating (2011) (2)
Oligonucleotide Production Gearing Up (2011) (2)
Neuraminidase inhibitors take bite out of influenza (1998) (2)
IBM joins SNP Consortium (2000) (2)
Before anyone knew the future nature of biotechnology (1998) (2)
Regenerative Medicine: Where the Genetic and Info Revolutions Converge (2004) (2)
Strategies for Optimizing Peptide Synthesis (2011) (2)
Cephalon adds to clinical disappointment in 1997 (1997) (2)
Rosetta Inpharmatics chips in (1997) (2)
Meeting Current Needs and Assessing Future Opportunities to Drive the Global Bioeconomy (2013) (2)
Finding a Bioreactor That's Right for You (2011) (2)
Biochemical characterization of cells transformed via transfection by feline sarcoma virus proviral DNA (1981) (2)
Structural flexibility of the SARS-CoV-2 genome relevant to variation, replication, pathogenicity, and immune evasion (2021) (2)
CEO Roundup: What's Ahead in 1996 (1996) (2)
Dementia Studies Making Strides (2011) (2)
Control of gene expression and the replication and pathogenesis of retroviruses. (1986) (2)
Circularization via complementary sequences in the 5' and 3' termini may facilitate replication of SARS coronaviruses (2022) (2)
American Aging Association (2000) (2)
Scaling Up Peptide Drugs (2013) (2)
An Interview with Steven M. Watkins, Ph.D. President and Chief Scientific Officer, Lipomics Technologies, Inc. (2004) (2)
Incision of Pyrimidine Dimer Containing DNA by Small Molecular Weight Enzymes (1981) (2)
The Kronos Group (2000) (2)
An Interview with Garry Nolan, Ph.D. (2009) (2)
Person-Centered Long-Term Care (2019) (2)
Pfizer targets genomics through Pfizergen (1995) (2)
FLUORESCENCE DETECTION SYSTEMS (1998) (1)
Desmosomes sort it out (2001) (1)
Researchers Seek Better Corn Through Tissue Culture (1984) (1)
Cloned cows turn back the cellular clock (2000) (1)
Gene transfer to the liver. (1996) (1)
Salmonella and rivals PREEMPTed from chickens (1998) (1)
U.S. biopharm firms up R&D spending 35% (1995) (1)
CARBOHYDRATE-BASED DRUGS MOVE CLOSER TO MARKET (1998) (1)
Researchers Tackle Herbicide Resistance (1983) (1)
Genentech relaunched with independence intact (1999) (1)
Myriad's lifestyle test targets borderline hypertensives (1998) (1)
Investigator Profile: An Interview with Robert Geisler, Ph.D. (2005) (1)
Sequencing Alters Medical Genetics (2011) (1)
PROCESSING MABS : COMPANIES PURSUE RANGE OF STRATEGIES FOR MONOCLONAL THERAPEUTICS (1998) (1)
An interview with William A. Haseltine. (2004) (1)
An Interview with Louis Miller, M.D. (2004) (1)
Healthcare in the United States (2019) (1)
ALS claims another victim (1997) (1)
Genomics: The Path Ahead for Science, Medicine, and Society (2001) (1)
11 – Replication and Pathogenesis of HIV-1 Retrovirus Relevant to Drug Design (1989) (1)
Tissue Engineering Revenues Rise (2012) (1)
Interview with Luke Alphey, Ph.D. (2009) (1)
Serum Profiling Making Mark on Predictive Medicine (2011) (1)
Human suffering in Vietnam. (1970) (1)
Incubating Bioweapons (1999) (1)
Takayuki Asahara, M.D., Ph.D. (2002) (1)
Structure and function of human leukemia and AIDS viruses. (1984) (1)
Drug companies like combinatorial chemistry (1995) (1)
Characterization of an IL-2 dependent human T-cell leukemia-virus type-I (HTLV-I) infected cell-line - a system for studying HTLV-I mediated transformation. (1994) (1)
Investigator Profile: An Interview with Zhiyuan Gong, Ph.D. (2004) (1)
Swiping and Tapping for Better Health (2016) (1)
Geron issued UK Dolly patents (2000) (1)
An Interview with Mr. Richard Archer; Former Chief Executive, The Automation Partnership, Cambridge, United Kingdom (2004) (1)
James D. Griffin, M.D., Harvard Medical School (2001) (1)
An Interview with Norman S. Wolf, D.V.M., Ph.D. (2003) (1)
Eight Lessons for Social Inclusion and High-Quality Sustainable Elder Care (2019) (1)
An Interview with Michael Carvan, Ph.D. (2004) (1)
The EPO IPO: Transkaryotic Therapies, Amgen, and gene therapy (1996) (1)
Analytical Chemistry, Microscopy, and Image Analysis (1984) (1)
The Ellison Medical Foundation (1998) (1)
New approaches to DNA damage and repair: the ultraviolet light example. (1982) (1)
Discovering Genes for New Medicines By identifying human genes involved in disease, researchers can create potentially therapeutic proteins and speed the development of powerful drugs (1997) (1)
JAIDS and Human Retrovirology (1995) (1)
NUCLEOTIDE EXCISION REPAIR OF DAMAGED DNA (1982) (1)
Consensus on future directions in Parkinson's disease research. (1995) (1)
Telethinking with Yulun Wang, Ph.D. (Interview by Vicki Glaser). (2005) (1)
Investigator profile. An interview with Keith Cheng, M.D., Ph.D. Interview by Vicki Glaser. (2006) (1)
DPI delivers biotechnology superstore (1998) (1)
Genes and Viruses Able to Transform Hematopoietic Cells Group Report (1985) (1)
Transformation with subgenomic fragments of feline sarcoma virus proviral DNA. (1981) (1)
Age-Related Diseases: Exploiting Mechanisms for Drug Development (1998) (1)
Novartis licenses gene therapy to avoid monopoly (1997) (1)
RNase L and 2-5A to enhance antisense technology and target the destruction of mRNA. (1996) (1)
Driving Mass Spec-Based Multiplexed Protein Biomarker Tests to the Clinic (2014) (1)
Of genes and genomes: what lies between the base pairs. (2000) (1)
Anti-inflammatory inflames Centocor's profits (1998) (1)
An Interview with Jerry W. Shay, Ph.D. (1999) (1)
Innovative programs in telemedicine. European Institute of Telesurgery (EITS)/WeBSurg. (2009) (1)
Merging Health and Social Services (2019) (1)
California to determine incidence of HIV infection in newborns. (1988) (0)
HPLC Summit Offers Expansive Biomolecular Views (2018) (0)
Small Molecules, Big Possibilities (2014) (0)
Protein Folding and Disease: The Path from Bench to Bedside (2012) (0)
HealthSpan Sciences, Inc. (1998) (0)
Too many surgeons for too few operations? (1990) (0)
Public companies spend over $4 billion on R&D (1996) (0)
Novel 3D Cell Culture Systems (2013) (0)
An Interview with Judith Campisi, Ph.D. (2000) (0)
Flip the DNA Nanoswitch, Power the Clinical App (2018) (0)
An Interview with Leeber S. Cohen, M.D. (2006) (0)
GeneTransfer intoHumanLymphocytes bya Defective Human Immunodeficiency VirusType1Vector (1991) (0)
Close-Up View of Life Science Microscopy (2012) (0)
Protein trans activating property, this protein-expressing vectors, cell lines and uses his. (1990) (0)
Interview with Steven A. Haney, PhD. (2014) (0)
FDA moves ahead in the fight against AIDS. (1988) (0)
Antagonistic drivers share BuMPy pathway (2001) (0)
BIOPROCESS CONTROL SOFTWARE : ADVANCING TECHNOLOGY AND INDUSTRY STANDARDS SIMPLIFY CONTROL STRATEGIES (1998) (0)
Tricks of the Trade for Cell Culture Optimization (2018) (0)
Soluble CD4: a new antiviral treatment for AIDS. (1990) (0)
Separation of Therapeutic Biomolecules (2013) (0)
An Interview with Stephen D. O'Connor, Ph.D. CEO, Nanostream (2006) (0)
Optimizing LC/MS for Drug Bioanalysis (2012) (0)
Telethinking With Adam Darkins, M.D. (2008) (0)
Stem Cell Peaks Yet Unscaled (2014) (0)
Wyeth-Ayerst and Apollon sign vaccine deal (1995) (0)
Range of NGS Applications Rises Quickly (2011) (0)
Albumin and interferon beta fusion proteins (2002) (0)
Pharmacia challenges Genentech in rhGH market (1995) (0)
An Interview with Robert Arking, Ph.D. (2000) (0)
Identification ofa Regionwithin theHumanImmunodeficiency VirusType1LongTerminal RepeatThatIsEssential for Transactivation bytheHepatitis B VirusGeneX (1989) (0)
Cancer Diagnostics: Pushing the Boundaries (2013) (0)
Interview with Mel Reichman, PhD. (2015) (0)
Transactivator Genes of HTLV-I, II, and III (1986) (0)
Study of polio vaccine's effects on AIDS faces roadblock. (1988) (0)
ADVANCES IN VIRAL VECTOR SCIENCE (1998) (0)
An Interview with Manfred Schartl, Ph.D. (2004) (0)
Genomic Analysis Drives Biomarker Discovery (2013) (0)
DNA Polymerase (Reverse Transcriptase) Specific Binding of Tryptophan Transfer RNA to Avian Myeloblastosis Virus RNA-Dependent (2006) (0)
Interview with Robert K. Washino, Ph.D. (2005) (0)
Genetically engineered mosquitoes fight infection (1996) (0)
An Interview with Stefan Duhr, PhD, and Moran Jerabek-Willemsen, PhD. (2011) (0)
Flow Cytometry Doubles as High-Content Analysis Tool (2012) (0)
Construction of a plasmid containing functional Escherichia coli uvrA, B, and C genes in a configuration potentially suitable for mammalian expression. (1984) (0)
Metagenomics Digs Up Microbiome Riches (2015) (0)
An interview with James Wilbur, Ph.D. General Manager, Life Sciences, Meso Scale Discovery. (2004) (0)
Telethinking With Yulun Wang, Ph.D. (2005) (0)
A Cornucopia of siRNA- and RNAi-based Therapeutics in Development Show Promise (2008) (0)
Determination ofViral Proteins Present intheHuman Immunodeficiency VirusType1 Preintegration Complex (1991) (0)
Fifth International Conference on AIDS : the Scientific and Social Challenge; symposium transcript; regulatory genes and viral genomic diversity (1989) (0)
An Interview with Salvador Contreras Balderas, Ph.D. (2006) (0)
Global Incentives Seek to Buoy Innovation: BIO2011 Highlighted Regional Perks Designed to Rapidly Move Advances from Lab to Market (2011) (0)
The Food and Drug Administration (2000) (0)
Construction and use of a replication-competent human immunodeficiency virus ( HIV-1 ) that expresses the chloramphenicol acetyltransferase enzyme ( marked viruses / replication studies / drug screening ) (0)
Intragenomic rearrangements involving 5′-untranslated region segments in SARS-CoV-2, other betacoronaviruses, and alphacoronaviruses (2023) (0)
Support for Those Living with Dementia and Their Caregivers (2019) (0)
Lighting the Way, Optogenetically (2016) (0)
AIDS antibodies may enhance viral infection. (1988) (0)
Resequencing Still Being Targeted (2013) (0)
Molecular Biology of the AIDS Virus: Ten Years of Discovery – Hope for the Future1 (1992) (0)
An Interview with Stefanos Chandakas, M.D., M.B.A., Ph.D. (2005) (0)
Home-Based Palliative Care and Aging in Place and Community (2019) (0)
Robert C. Gallo, M.D. (2002) (0)
4981790 Stable tatIII cell lines, tatIII gene products, and assay methods (1991) (0)
An Interview with Michael M. Gottesman, M.D. (2009) (0)
Up- and Downstream Go Single Use (2012) (0)
Promoting bicycle helmet use in children. (1990) (0)
DPI delivers biotechnology superstore. Discovery Partners International. (1998) (0)
Competition between flu drugs feverishly anticipated (1999) (0)
Intragenomic rearrangements in SARS-CoV-2, other betacoronaviruses, and alphacoronaviruses (2022) (0)
Envelope Glycoprotein andCD4Independence of vpu-Facilitated HumanImmunodeficiency VirusType1Capsid Export (1992) (0)
Structural Analysis oftheGenomes ofGibbon ApeandWoolly MonkeyLeukosis Viruses (1979) (0)
ASTHMA THERAPEUTIC COMPANIES TARGET A GROWING $9BN MARKET (1998) (0)
Enabling Tools Extend the Range of HCA (2011) (0)
Cis-effect repression sequences, cis-effect anti-repression sequences, vectors, methods for the preparation and application. (1988) (0)
Interview with Thomas P. Monath, M.D. (2005) (0)
Nanoliter Volumes Push MS to New Lows (2011) (0)
Letter from William A. Haseltine, Dana-Farber Cancer Institute to Harold Varmus (1985) (0)
An interview with William A. Haseltine. (2004) (0)
Progenics, Somatix in phase III cancer vaccine trials. (1996) (0)
Interview with C. David Allis, PhD. (2015) (0)
Improving In Vivo Small Animal Imaging (2013) (0)
Telethinking With Karen S. Rheuban, M.D. (2009) (0)
Tagged From birth (2001) (0)
TRENDS IN DRUG DISCOVERY (1998) (0)
Small-Scale Modeling and Predicting (2012) (0)
An Interview with Zuoyan Zhu, Ph.D. (2005) (0)
Cancer Detection Improved with Noninvasive Testing (2011) (0)
A Career Path in Arbovirology—An Interview with Robert E. Shope, M.D. (2003) (0)
The Haiku and the Double Helix ‐ Fall 2004 (2008) (0)
Faster, Cheaper Sequencing & Drug Discovery Drive HGP Commercialization (2021) (0)
Investigator Profile: An Interview with Daniel Chourrout, Ph.D. (2004) (0)
Good Assays for Bad Immunogenicity (2017) (0)
Osteoarthritis, shoulder impingement, cervical radiculopathy, plantar fasciitis (1999) (0)
NGS Systems Secure Place in Clinic (2014) (0)
Health System in Singapore (2019) (0)
Interrupting Cell Signaling (2013) (0)
Annals of the New York Academy of Sciences: origins and evolution of eukaryotic intracellular organelles. (1981) (0)
Transcription factors with trans activity. (1985) (0)
Verpackungsdefizientes HIV provirus, cell lines and their use. (1990) (0)
Interview with Joon Yun, MD. (2015) (0)
Tales from the crypt (2001) (0)
New Peaks in Hydrophobic Bioprocessing (2017) (0)
Pheromone firms cooperate to speed approvals (1995) (0)
Investigator Profile: An Interview with A. Thomas Look, M.D. (2005) (0)
An Interview with Jeffrey S. Dungan, M.D. (2007) (0)
Aquila arises from ashes of Cambridge Biotech (1996) (0)
Lung cancer rates decreasing for young people in US. (1990) (0)
Cancer Immunotherapy Spurs Work on Better Animal Models (2017) (0)
Bioreactor Market Growth Spurs Innovation (2012) (0)
Interview with Daniel E. Sonenshine, Ph.D. (2006) (0)
An Interview with Gabriela G. Cezar, D.V.M., Ph.D. (2009) (0)
Structure and pathology of the human T-lymphotrophic retrovirus type III (1988) (0)
Identification ofIndividual HumanImmunodeficiency VirusType1 gpl20AminoAcidsImportant forCD4Receptor Binding (1990) (0)
Telethinking: with Right Honorable Lord Roger Swinfen and Lady Pat Swinfen. Interview by Vicki Glaser. (2008) (0)
Molecular Biology: Retroviruses (1990) (0)
Making the Transition from an Academic to a Biobusiness Entrepreneur (2021) (0)
Saliva shown to inhibit HIV-1 infectivity. (1988) (0)
Part II: Beating COVID-19 Means Tipping the Balance of an Age-Old Struggle (2022) (0)
Promising results with drugs for chemoprophylaxis of Pneumocystis carinii pneumonia in AIDS. (1988) (0)
An Interview with Paul England, Ph.D., ProXara Biotechnology, Ltd. (2004) (0)
miRNAs & Psychiatric Disorders (2012) (0)
152 U.S. biopharmaceutical firms lose $13 billon (1995) (0)
An Interview with Richard Faragher, D.Phil. (2003) (0)
Purpose and Social Inclusion (2019) (0)
Chris Curtis, Ph.D. (2004) (0)
Arp bent out of shape (2001) (0)
One Algorithm. Many Cures. Zero Cancer (2016) (0)
The Sunshine Foundation (2003) (0)
Coordinated Primary Care (2019) (0)
Interview with Alex Zhavoronkov, PhD. (2015) (0)
Another Genentech–Novo battle looms in the hGH patent war (1997) (0)
An Interview with Gary H. Lipscomb, M.D. (2005) (0)
FASTER, BETTER GENE SEQUENCING (1998) (0)
Berlex continues legal challenge to FDA over MS drug (1996) (0)
An Interview with Michel Bouvier, Ph.D. (2006) (0)
An Interview with Jeffrey R. Dell, M.D. (2005) (0)
Personal profile: interview with Tanja Dominko, DVM, PhD. (2014) (0)
Broadening the Focus of In Vivo Imaging (2011) (0)
Dental Gene Cloned; May Lead to Better Fillings and Teeth (1984) (0)
An Interview with Jeffrey Price, M.D., Ph.D. (2005) (0)
An Interview with Richard Weindruch, Ph.D. (2000) (0)
Dispensing with Manual Pipetting (2011) (0)
Risk factors for teenage suicide. (1990) (0)
Cis-acting repression and cis-acting antirepression sequences, vector, its preparation and use thereof (1988) (0)
Progress in Stem Cell Pluripotency (2014) (0)
New flu treatments only a sniff away (1997) (0)
Revealing Subcellular Heterogeneity (2012) (0)
“Ganske” threatens biotechnology patents worldwide (1997) (0)
E&Y notes shift in new BT activity (1998) (0)
Clinical costs escalate biotechnology's R&D expenses (1996) (0)
Interview with Jill Jarecki, PhD. (2014) (0)
The value of on-site healthcare delivery for inner-city children. (2009) (0)
E. Donnall Thomas, M.D., Nobel Laureate in medicine. Interview by Vicki P. Glaser. (2000) (0)
An Interview with Leonard Guarente, Ph.D. (2001) (0)
An Interview with Lyle Petersen, M.D., M.P.H. (2004) (0)
Dark Side of the Genome: Study Links Noncoding Mutations in Regulatory Regions of the Cancer Genome to Altered Gene Expression (2018) (0)
Vpuprotein ofhumanimmunodeficiency virus type1enhances the release ofcapsids produced bygaggeneconstructs ofwidely divergent retroviruses (1993) (0)
An Interview with Stephen A. Grochmal, M.D. (2005) (0)
EpiStem, Ltd. [interview by Vicki P. Glaser]. (2002) (0)
Expression of endogenous retroviruses in thymic lymphomas of akr mice. Abstr. (1981) (0)
Peptides for the diagnosis of antibodies to HTLV-III, their preparation and use. (1987) (0)
Myriad pulls IPO from inhospitable market (1997) (0)
Professor C.S. Potten (2002) (0)
BIOPROCESS CONTROL SYSTEMS (1999) (0)
Emergency Medicine and Hospital Care in the Home and Community (2019) (0)
Gene Therapy Comes of Age (2015) (0)
PROTEIN CHIPS AND MASS SPEC BOLSTER PROTEOMICS RESEARCH (1998) (0)
HIV blocker (2001) (0)
5 Gene therapy of viral infections: The use of retroviral vectors expressing catalytic and antisense RNAs (1993) (0)
Metaproterenol inhaler taken off market. (1990) (0)
Part 1: Beating COVID-19 Means Tipping the Balance of an Age-Old Struggle (2022) (0)
Biotech unruffled by setbacks (1997) (0)
Mechanism of leukemogenesis by human T-cell leukemia virus types I and II: role of the lor gene. (1987) (0)
Medicine: Getting Personal (2013) (0)
The rise and fall and rise of CBC (1996) (0)
An Interview with Barbara Gilchrest, M.D. (2002) (0)
A tribute to Dr. William A. Haseltine. Interview by Val J. Halamandaris. (2003) (0)
BIOPROCESS SIMULATION SOFTWARE (1999) (0)
Determination of virulence properties of leukemia viruses. (1983) (0)
An Interview with Richard M. Eglen, Ph.D. Vice President and General Manager, Discovery and Research Reagents, Molecular Medicine, PerkinElmer Life and Analytical Sciences (2006) (0)
An Interview with Lee P. Shulman, M.D. (2006) (0)
PE/TIGR provokes genome sequencing skeptics (1998) (0)
An Interview with Ronald M. Evans, Ph.D. Investigator, The Salk Institute for Biological Studies (2003) (0)
HIV provirus defective for packaging cell lines and their use. (1990) (0)
Telethinking with Rifat Latifi, M.D. Interview by Vicki Glaser. (2009) (0)
Interview with Charles H. Calisher, Ph.D. (2005) (0)
British Society for Research on Ageing (2002) (0)
New Cancer Research Tools Change Paradigm (2011) (0)
Celebrating the Double Helix (1983) (0)
The Van Andel Institute (1999) (0)
Desperately Seq'ing RNA (2015) (0)
Roleofcapsid precursor processing andmyristoylation in morphogenesis andinfectivity ofhuman immunodeficiency virus type1 (1989) (0)
Fusion proteins albumin and GCSF (2002) (0)
TRENDS IN PHARMACOGENOMICS (1999) (0)
CORPORATE PROFILE ATHEROGENICS ATTACKS PLAQUE (1999) (0)
Inhibition of human immunodeficiency virus syncytium formatioin and virus replication by castanospermine ( acquired immunodeficiency syndrome / glycosylation inhibitor / human immunodeficiency virus envelope glycoprotein processing / antiretroviral agent (0)
Flow of novel genes for R&D continues (1998) (0)
An Interview with Sheila Collins, Ph.D. (2005) (0)
Intragenomic rearrangements of SARS-CoV-2 and other β-coronaviruses (2022) (0)
Sugen's strategy: a signal for P&U purchase (1999) (0)
The Buck Center for Research in Aging (1999) (0)
STRATEGIES TO ACCELERATE LEAD DISCOVERY (1999) (0)
An Interview with Chris Curtis, Ph.D. (2004) (0)
Value of PCR Amplified as It Moves to Clinic (2011) (0)
Radiation resistance genes discovered (2001) (0)
Every Second Counts: Saving Lives with India's Emergency Response System (2018) (0)
Excellent but narrow virus reviews Molecular biology of RNA tumor viruses. J. R. Stephenson, ed. New York: Academic Press. (1980). 527 pp. $49.50 (1980) (0)
An Interview with John Erian, M.B.B.Ch., F.R.C.O.G. (2006) (0)
The effect of zidovudine on antigen levels in HIV infection. (1988) (0)
Mass Customization of Stem Cells (2015) (0)
Anthropologists in the Lab (2005) (0)
The Business of Biotechnology: Regional Activity Lures New Companies (1984) (0)
Finer Screens for Circulating Tumor Markers (2014) (0)
An Interview with Robert Butler, M.D. (1998) (0)
Screening Innovations Proliferate (2011) (0)
With James A. Brink, M.D. (2006) (0)
Interview with Scott B. Halstead, M.D. (2007) (0)

This paper list is powered by the following services:

Other Resources About William A. Haseltine

en.wikipedia.org

What Schools Are Affiliated With William A. Haseltine?

William A. Haseltine is affiliated with the following schools:

Image Attributions

Image Source for William A. Haseltine